July 6, 2020 / 11:07 AM / a month ago

BRIEF-Precision BioSciences Says Will Regain Full Rights, All Data It Generated For HBV Program Developed Under Agreement With Gilead Sciences

July 6 (Reuters) - Precision BioSciences Inc:

* PRECISION BIOSCIENCES REGAINS RIGHTS TO IN VIVO HEPATITIS B VIRUS PROGRAM

* PRECISION BIOSCIENCES - WILL REGAIN FULL RIGHTS AND ALL DATA IT GENERATED FOR HBV PROGRAM DEVELOPED UNDER 2018 AGREEMENT WITH GILEAD SCIENCES

* PRECISION BIOSCIENCES - DOES NOT ANTICIPATE ANY CHANGES TO ITS CASH RUNWAY

* PRECISION BIOSCIENCES - AS OF MARCH 31, HAD CASH AND CASH EQUIVALENTS OF $154.2 MILLION, EXPECTED TO SUFFICIENTLY FUND OPERATIONS INTO H2 OF 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below